June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

August 24, 2015August 25, 2015

Radio Host and Research Center Founder Sharon Kleyne Reports on Dangers of Malignant Melanoma, Sun Exposure and Dehydration

News

With summers coming in earlier and lasting longer, and the sun’s UV rays growing all the more harsh in several parts of America, Sharon Kleyne, host of the Sharon Kleyne Hour Power ... Read more

August 21, 2015August 21, 2015

Having Fewer Moles Could Correlate To Worse Melanoma Diagnosis

News

When it comes to predicting risk for skin cancer, many of us, including physicians, believe having more than 50 moles puts one at a much higher risk of developing melanoma. ... Read more

August 19, 2015August 19, 2015

New Therapeutic Approach for Metastatic Melanoma Based on Pin1-FOXM1 Interaction

News

A study recently published in the journal Oncogene revealed a new therapeutic strategy for advanced metastatic melanoma based on the interaction between two particular factors – Pin1 and FOXM1. The ... Read more

August 17, 2015August 17, 2015

Study Shows Increased Melanoma Risk Among Transplant Recipients

News

A research team from Johns Hopkins Bloomberg School of Public Health found transplant recipients are more likely to develop aggressive forms of melanoma. The study entitled “Melanoma Risk and Survival Among ... Read more

August 14, 2015August 14, 2015

Pan Am Cancer Treatment Center Announces Availability Of ImmunoMax For Advanced Cancer Patients

News

The Pan Am Cancer Treatment Center, an institution committed to provide top immunotherapies to cancer patients, has recently announced ImmunoMax is available to patients with advanced cancer, including melanoma, that meet all the necesary ... Read more

August 12, 2015August 12, 2015

Mobile Applications for Melanoma Detection Market Analysis And Market Forecast For 2014 – 2022 Released

News

Incidence of Malignant Melanoma — the most aggressively deadly type of skin cancer — is increasing globally. According to the Skin Cancer Foundation, one person dies of melanoma in the ... Read more

August 10, 2015August 10, 2015

Pregnancy Does Not Influence Melanoma Prognosis

News

Results from a recent study published in the journal Dermatologic Surgery have shown that women who became pregnant after being diagnosed with melanoma did not experience a significantly worse clinical prognosis. ... Read more

August 7, 2015August 7, 2015

Key Genetic Factor Controls Mole Development Into Melanoma

News

Researchers at the University of Pennsylvania and the Wistar Institute recently discovered a key genetic factor that maintains skin moles in a non-cancerous, no-growth state. The study was published in ... Read more

August 5, 2015August 5, 2015

Researchers Discover the Trigger for Invasive, Lethal Melanoma

News

A recent study led by researchers at Tel Aviv University (TAU) in Israel revealed the trigger that causes melanoma cells to transform into invasive, lethal cells. The study is entitled ... Read more

August 3, 2015August 3, 2015

Researchers Identify a New Gene Mutation in Melanoma Patients

News

A research team from the Yale University School of Medicine has identified one of the most frequent gene mutations in melanoma skin cancer patients. The study entitled “Exome sequencing identifies ... Read more

July 31, 2015August 3, 2015

Castle Biosciences Receives Funding For Its DecisionDx-Melanoma Test

News

Castle Biosciences a company that develops and commercializes diagnostic and prognostic tests for cancers, recently announced it has raised $11.7 million to support the clinical adoption of the company’s DecisionDx-Melanoma ... Read more

July 29, 2015July 29, 2015

Novel Clinical Trial for BRAFV600-Advanced Melanoma Initiates Patient Recruitment

News

The ECOG-ACRIN Cancer Research Group recently announced it will begin patient enrolment in its Phase III cancer clinical trial that will compare two differently acting treatments that have previously shown to be effective ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group